References
- SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
- BonapaceLCoissieuxMMWyckoffJMertzKDVargaZJuntTBentires-AljMCessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesisNature2014515752513013325337873
- LluchACuevaJRuiz-BorregoMPonceJPérez-FidalgoJAZoledronic acid in the treatment of metastatic breast cancerAnticancer Drugs20142511724100278
- CasasALlombartAMartínMDenosumab for the treatment of bone metastases in advanced breast cancerBreast201322558559223759273
- KangYSiegelPMShuWA multigenic program mediating breast cancer metastasis to boneCancer Cell20033653754912842083
- YinJJSelanderKChirgwinJMTGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases developmentJ Clin Invest199910321972069916131
- EckhardtBLFrancisPAParkerBSAndersonRLStrategies for the discovery and development of therapies for metastatic breast cancerNat Rev Drug Discov201211647949722653217
- HongCANamYSFunctional nanostructures for effective delivery of small interfering RNA therapeuticsTheranostics20144121211123225285170
- MieleESpinelliGPMieleEDi FabrizioEFerrettiETomaoSGulinoANanoparticle-based delivery of small interfering RNA: challenges for cancer therapyInt J Nanomedicine201273637365722915840
- DangLLiuJLiFTargeted delivery systems for molecular therapy in skeletal disordersInt J Mol Sci201617342844327011176
- SunHZuYAptamers and their applications in nanomedicineSmall201511202352236425677591
- LiangCGuoBWuHAptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategyNat Med201521328829425665179
- CowinSCCardosoLBlood and interstitial flow in the hierarchical pore space architecture of bone tissueJ Biomech201548584285425666410
- BlancoEShenHFerrariMPrinciples of nanoparticle design for overcoming biological barriers to drug deliveryNat Biotechnol201533994195126348965
- CarmelietPAngiogenesis in life, disease and medicineNature2005438707093293616355210
- FukumuraDJainRKTumor microvasculature and microenvironment: targets for anti-angiogenesis and normalizationMicrovasc Res2007742–3728417560615
- MiJRayPLiuJIn vivo selection against human colorectal cancer xenografts identifies an aptamer that targets RNA helicase protein DHX9Mol Ther Nucleic Acids20165e31527115840
- FolkmanJToward an understanding of angiogenesis: search and discoveryPerspect Biol Med198529110362415913
- KerbelRSInhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agentsBioessays199113131361722975
- FolkmanJAngiogenesis in cancer, vascular, rheumatoid and other diseaseNat Med19951127307584949
- IngberDFujitaTKishimotoSSynthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature199034863015555571701033
- KimKJLiBWinerJArmaniniMGillettNPhillipsHSFerraraNInhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature199336264238418447683111
- O’ReillyMSHolmgrenLShingYAngiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinomaCell19947923153287525077
- BrekkenRAOverholserJPStastnyVAWaltenbergerJMinnaJDThorpePESelective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in miceCancer Res200060185117512411016638
- IshidaTKunduRKYangEHirataKHoYDQuertermousTTargeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivoJ Biol Chem200327836345983460412819200
- AirdWCEndothelial cell heterogeneityCold Spring Harb Perspect Med201221a00642922315715